{
    "organizations": [],
    "uuid": "417e17d4bcf1f4fc83bccc45a9dd8ff1223e194a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL8N1QJ4GS",
    "ord_in_thread": 0,
    "title": "PFR Life Science Buys Shares Of Selvita For Around 40 Mln Zlotys",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - SELVITA SA:\n* SAYS THAT PFR LIFE SCIENCE ACQUIRED COMPANYâ€™S SHARES WORTH AROUND 40 MILLION ZLOTYS IN PUBLIC OFFER\n* TOTAL VALUE OF OFFER AMOUNTED TO OVER 134 MILLION ZLOTYS * FUNDS RAISED IN OFFER COMPANY PLANS TO SPEND ON IMPLEMENTATION OF ITS 2017-2021 STRATEGY ANNOUNCED IN AUGUST, 2017\n* ESTIMATES THAT TOTAL INVESTMENT COSTS IN YEARS 2017-2021 WILL REACH 390 MILLION ZLOTYS\nSource text: bit.ly/2CPz25K Source text for Eikon:\n (Gdynia Newsroom)\n ",
    "published": "2018-03-01T19:42:00.000+02:00",
    "crawled": "2018-03-02T20:12:12.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "selvita",
        "sa",
        "say",
        "pfr",
        "life",
        "science",
        "acquired",
        "company",
        "share",
        "worth",
        "around",
        "million",
        "zloty",
        "public",
        "offer",
        "total",
        "value",
        "offer",
        "amounted",
        "million",
        "zloty",
        "fund",
        "raised",
        "offer",
        "company",
        "plan",
        "spend",
        "implementation",
        "strategy",
        "announced",
        "august",
        "estimate",
        "total",
        "investment",
        "cost",
        "year",
        "reach",
        "million",
        "zloty",
        "source",
        "text",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}